Zimbabwe has turned down a major American health deal valued at $367m (272 million pounds) over five years because of Washington's request for confidential biological samples.
The decision was revealed after a official document dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "unbalanced".
A government spokesperson has since explained that the US was demanding access to biological samples for scientific study and commercial purposes but was unwilling to share the resulting advantages from future medical innovations.
"We will now turn to the difficult and regrettable process of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had provided over $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for continued talks to reach a agreement acceptable to both sides so the country's critical HIV programme can continue.
Broader Implications
This rejection follows a similar situation in neighbouring Kenya, where a high court halted a related health funding agreement after concerns were raised about the safety of Kenyans' health data.
Since returning to office recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
USAID had managed assistance for the American government, but Trump claimed its expenditure was "wasteful" and his government was pursuing direct bilateral deals to boost transparency and responsibility.
According to reports, Sixteen African countries have to date agreed to similar agreements, representing over $18.3bn in committed funds.
Specifics of the Rejected Agreement
The money for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation might have yielded immense benefits for the people of Zimbabwe, particularly the 1.2 million presently on HIV treatment through American-funded programmes," Tremont commented.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to share its biological resources and data for a long time, with no corresponding guarantee of benefiting from any medical innovations – like new medicines or tests – that could be developed from that shared data," he stated.
"In essence, our country would supply the basic resources for scientific discovery with no certainty that the resulting innovations would be available to our people if a future health crisis arise."
National Interest and Global Health
He also pointed out that the American exit from the global health body and its pursuit of one-on-one deals were upending structures previously set up via the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with potential global health emergencies.
"This mechanism is designed to ensure that when a country provides its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to develop them."
These objections regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome further discussions with our American counterparts on how subsequent collaboration could be designed in a way that respects the independence and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but urged that negotiations need to persist given that a large portion of the country's HIV programmes depended on international support.
"In cases where technical issues arise, such as those relating to information security or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," the group added.
The situation emphasises the ongoing debate between receiving much-needed international aid and safeguarding national sovereignty in an increasingly interconnected world.